P

Inventor

ALESSI THOMAS R

US29 patents
⚠️ This page may combine multiple inventors who share the name “ALESSI THOMAS R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INTARCIA THERAPEUTICS INC

14 patents
US7879028B2Feb 1, 2011

Osmotic delivery systems and piston assemblies for use therein

INTARCIA THERAPEUTICS INC72 citations97
US7682356B2Mar 23, 2010

Osmotic delivery systems and piston assemblies for use therein

INTARCIA THERAPEUTICS INC84 citations97
US9682127B2Jun 20, 2017

Osmotic delivery device comprising an insulinotropic peptide and uses thereof

INTARCIA THERAPEUTICS INC21 citations94
US9572889B2Feb 21, 2017

Devices, formulations, and methods for delivery of multiple beneficial agents

INTARCIA THERAPEUTICS INC23 citations93
US9889085B1Feb 13, 2018

Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c

INTARCIA THERAPEUTICS INC18 citations91
US8343140B2Jan 1, 2013

Devices, formulations, and methods for delivery of multiple beneficial agents

INTARCIA THERAPEUTICS INC30 citations91
US11246913B2Feb 15, 2022

Suspension formulation comprising an insulinotropic peptide

INTARCIA THERAPEUTICS INC0 citations62
US12042557B2Jul 23, 2024

Rapid establishment and/or termination of substantial steady-state drug delivery

INTARCIA THERAPEUTICS INC0 citations58
US10527170B2Jan 7, 2020

Osmotic delivery systems and piston assemblies for use therein

INTARCIA THERAPEUTICS INC0 citations52
US10363287B2Jul 30, 2019

Method of manufacturing an osmotic delivery device

INTARCIA THERAPEUTICS INC0 citations52
US10441528B2Oct 15, 2019

Devices, formulations, and methods for delivery of multiple beneficial agents

INTARCIA THERAPEUTICS INC0 citations50
US10583080B2Mar 10, 2020

Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c

INTARCIA THERAPEUTICS INC0 citations49
US10869830B2Dec 22, 2020

Rapid establishment and/or termination of substantial steady-state drug delivery

INTARCIA THERAPEUTICS INC0 citations48
US10231923B2Mar 19, 2019

Rapid establishment and/or termination of substantial steady-state drug delivery

INTARCIA THERAPEUTICS INC0 citations48

AMERICAN HOME PROD

9 patents

ALESSI THOMAS R

5 patents

DISCOVERY LAB INC

1 patent